A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder

Míreanna Comhchosúla

• A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder
  le: Mahableshwarkar, Atul R, et al.
  Foilsithe: (2016)
• Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
  le: Alam, Mohammed Y., et al.
  Foilsithe: (2014)
• A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD
  le: Mahableshwarkar, Atul R., et al.
  Foilsithe: (2015)
• Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
  le: Jacobsen, Paula L., et al.
  Foilsithe: (2015)
• Randomized, double‐blind, placebo‐controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder
  le: Inoue, Takeshi, et al.
  Foilsithe: (2019)